Quick Answer
Artiva Biotherapeutics, Inc. reported Total Revenue of $251.0 thousand for fiscal year 2024.
Artiva Biotherapeutics, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2024 | $251.0K | -99.3% |
| 2023 | $33.49M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2023 | $26.66M | — | +662.3% |
| June 30, 2023 | $3.50M | — | — |
- Artiva Biotherapeutics, Inc. showed a decrease of -99.3% in Total Revenue compared to the prior fiscal year.
- Over the 2023–2024 period, Artiva Biotherapeutics, Inc.’s total revenue has declined by 99.3% (from $33.49 million to $251.0 thousand).
- The most recent figure is from Artiva Biotherapeutics, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 24, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: